{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:50:44Z","timestamp":1771012244083,"version":"3.50.1"},"reference-count":214,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1093\/toxsci\/kfj101","type":"journal-article","created":{"date-parts":[[2006,1,13]],"date-time":"2006-01-13T02:08:45Z","timestamp":1137118125000},"page":"400-418","source":"Crossref","is-referenced-by-count":31,"title":["Genetic Alterations in Cancer Knowledge System: Analysis of Gene Mutations in Mouse and Human Liver and Lung Tumors"],"prefix":"10.1093","volume":"90","author":[{"given":"Marcus A.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Lea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyamal D.","family":"Peddada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June K.","family":"Dunnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,1,12]]},"reference":[{"key":"key\n\t\t\t\t20171013192915_BIB1","unstructured":"Albertini, R. J., and Hayes, R. B. (1997). Somatic cell mutations in cancer epidemiology. IARC Sci. Publ.142,159\u2013184."},{"key":"key\n\t\t\t\t20171013192915_BIB2","doi-asserted-by":"crossref","unstructured":"An, F. Q., Matsuda, M., Fujii, H., Tang, R. F., Amemiya, H., Dai, Y. M., and Matsumoto, Y. (2001). Tumor heterogeneity in small hepatocellular carcinoma: Analysis of tumor cell proliferation, expression and mutation of p53 AND beta-catenin. Int. J. Cancer93,468\u2013474.","DOI":"10.1002\/ijc.1367"},{"key":"key\n\t\t\t\t20171013192915_BIB3","unstructured":"Anna, C. H., Sills, R. C., Foley, J. F., Stockton, P. S., Ton, T. V., and Devereux, T. R. (2000). Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. Cancer Res.60,2864\u20132868."},{"key":"key\n\t\t\t\t20171013192915_BIB4","doi-asserted-by":"crossref","unstructured":"Aydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A., and Schwarz, M. (2001). Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene20,7812\u20137816.","DOI":"10.1038\/sj.onc.1204982"},{"key":"key\n\t\t\t\t20171013192915_BIB5","doi-asserted-by":"crossref","unstructured":"Bai, F., Nakanishi, Y., Takayama, K., Pei, X. H., Inoue, K., Harada, T., Izumi, M., and Hara, N. (2003). Codon 64 of K-ras gene mutation pattern in hepatocellular carcinomas induced by bleomycin and 1-nitropyrene in A\/J mice. Teratog. Carcinog. Mutagen(Suppl. 1), 161\u2013170.","DOI":"10.1002\/tcm.10071"},{"key":"key\n\t\t\t\t20171013192915_BIB6","doi-asserted-by":"crossref","unstructured":"Bai, F., Nakanishi, Y., Takayama, K., Pei, X. H., Tokiwa, H., and Hara, N. (1998). Ki-ras mutation and cell proliferation of lung lesions induced by 1-nitropyrene in A\/J mice. Mol. Carcinog.22,258\u2013264.","DOI":"10.1002\/(SICI)1098-2744(199808)22:4<258::AID-MC7>3.0.CO;2-F"},{"key":"key\n\t\t\t\t20171013192915_BIB7","doi-asserted-by":"crossref","unstructured":"Balmain, A. (2002). Cancer as a complex genetic trait: Tumor susceptibility in humans and mouse models. Cell108,145\u2013152.","DOI":"10.1016\/S0092-8674(02)00622-0"},{"key":"key\n\t\t\t\t20171013192915_BIB8","doi-asserted-by":"crossref","unstructured":"Bauer-Hofmann, R., Buchmann, A., Wright, A. S., and Schwarz, M. (1990). Mutations in the Ha-ras proto-oncogene in spontaneous and chemically induced liver tumours of the CF1 mouse. Carcinogenesis11,1875\u20131877.","DOI":"10.1093\/carcin\/11.10.1875"},{"key":"key\n\t\t\t\t20171013192915_BIB9","doi-asserted-by":"crossref","unstructured":"Bauer-Hofmann, R., Klimek, F., Buchmann, A., Muller, O., Bannasch, P., and Schwarz, M. (1992). Role of mutations at codon 61 of the c-Ha-ras gene during diethylnitrosamine-induced hepatocarcinogenesis in C3H\/He mice. Mol. Carcinog.6,60\u201367.","DOI":"10.1002\/mc.2940060110"},{"key":"key\n\t\t\t\t20171013192915_BIB10","doi-asserted-by":"crossref","unstructured":"Benzer, S., and Freese, E. (1958). Induction of specific mutations with 5-bromouracil. Proc. Natl. Acad. Sci. U.S.A.44,112\u2013119.","DOI":"10.1073\/pnas.44.2.112"},{"key":"key\n\t\t\t\t20171013192915_BIB11","doi-asserted-by":"crossref","unstructured":"Birney, E., Clamp, M., and Hubbard, T. (2002). Databases and tools for browsing genomes. Annu. Rev. Genomics Hum. Genet.3,293\u2013310.","DOI":"10.1146\/annurev.genom.3.030502.101529"},{"key":"key\n\t\t\t\t20171013192915_BIB12","doi-asserted-by":"crossref","unstructured":"Blankenburg, S., Konig, I. R., Moessner, R., Laspe, P., Thoms, K. M., Krueger, U., Khan, S. G., Westphal, G., Berking, C., Volkenandt, M., et al. (2005). Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: A case-control study. Carcinogenesis26,1085\u20131090.","DOI":"10.1093\/carcin\/bgi055"},{"key":"key\n\t\t\t\t20171013192915_BIB13","doi-asserted-by":"crossref","unstructured":"Boix-Ferrero, J., Pellin, A., Blesa, R., Adrados, M., and Llombart-Bosch, A. (1999). Absence of p53 gene mutations in hepatocarcinomas from a Mediterranean area of Spain. A study of 129 archival tumour samples. Virchows Arch.434,497\u2013501.","DOI":"10.1007\/s004280050374"},{"key":"key\n\t\t\t\t20171013192915_BIB14","doi-asserted-by":"crossref","unstructured":"Bourdon, J. C., D'Errico, A., Paterlini, P., Grigioni, W., May, E., and Debuire, B. (1995). p53 Protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology108,1176\u20131182.","DOI":"10.1016\/0016-5085(95)90217-1"},{"key":"key\n\t\t\t\t20171013192915_BIB15","doi-asserted-by":"crossref","unstructured":"Bressac, B., Kew, M., Wands, J., and Ozturk, M. (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature350,429\u2013431.","DOI":"10.1038\/350429a0"},{"key":"key\n\t\t\t\t20171013192915_BIB16","unstructured":"Brose, M. S., Volpe, P., Feldman, M., Kumar, M., Rishi, I., Gerrero, R., Einhorn, E., Herlyn, M., Minna, J., Nicholson, A., et al. (2002). BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res.62,6997\u20137000."},{"key":"key\n\t\t\t\t20171013192915_BIB17","doi-asserted-by":"crossref","unstructured":"Buchmann, A., Bauer-Hofmann, R., Mahr, J., Drinkwater, N. R., Luz, A., and Schwarz, M. (1991). Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: Correlation with susceptibility to hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A.88,911\u2013915.","DOI":"10.1073\/pnas.88.3.911"},{"key":"key\n\t\t\t\t20171013192915_BIB18","doi-asserted-by":"crossref","unstructured":"Buetow, K. H., Sheffield, V. C., Zhu, M., Zhou, T., Shen, F. M., Hino, O., Smith, M., McMahon, B. J., Lanier, A. P., London, W. T., et al. (1992). Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas. Proc. Natl. Acad. Sci. U.S.A.89,9622\u20139626.","DOI":"10.1073\/pnas.89.20.9622"},{"key":"key\n\t\t\t\t20171013192915_BIB19","unstructured":"Candrian, U., You, M., Goodrow, T., Maronpot, R. R., Reynolds, S. H., and Anderson, M. W. (1991). Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL\/6 x C3H F1 mice. Cancer Res.51,1148\u20131153."},{"key":"key\n\t\t\t\t20171013192915_BIB20","doi-asserted-by":"crossref","unstructured":"Cariello, N. F., Keohavong, P., Kat, A. G., and Thilly, W. G. (1990). Molecular analysis of complex human cell populations: Mutational spectra of MNNG and ICR-191. Mutat. Res.231,165\u2013176.","DOI":"10.1016\/0027-5107(90)90023-W"},{"key":"key\n\t\t\t\t20171013192915_BIB21","doi-asserted-by":"crossref","unstructured":"Challen, C., Lunec, J., Warren, W., Collier, J., and Bassendine, M. F. (1992). Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology16,1362\u20131366.","DOI":"10.1002\/hep.1840160610"},{"key":"key\n\t\t\t\t20171013192915_BIB22","doi-asserted-by":"crossref","unstructured":"Chao, H. K., Tsai, T. F., Lin, C. S., and Su, T. S. (1999). Evidence that mutational activation of the ras genes may not be involved in aflatoxin B(1)-induced human hepatocarcinogenesis, based on sequence analysis of the ras and p53 genes. Mol. Carcinog.26,69\u201373.","DOI":"10.1002\/(SICI)1098-2744(199910)26:2<69::AID-MC1>3.0.CO;2-A"},{"key":"key\n\t\t\t\t20171013192915_BIB23","doi-asserted-by":"crossref","unstructured":"Chen, B., Liu, L., Castonguay, A., Maronpot, R. R., Anderson, M. W., and You, M. (1993). Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis14,1603\u20131608.","DOI":"10.1093\/carcin\/14.8.1603"},{"key":"key\n\t\t\t\t20171013192915_BIB24","doi-asserted-by":"crossref","unstructured":"Chen, B., You, L., Wang, Y., Stoner, G. D., and You, M. (1994). Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens. Carcinogenesis15,2031\u20132035.","DOI":"10.1093\/carcin\/15.9.2031"},{"key":"key\n\t\t\t\t20171013192915_BIB25","doi-asserted-by":"crossref","unstructured":"Cooper, C. A., Carby, F. A., Bubb, V. J., Lamb, D., Kerr, K. M., and Wyllie, A. H. (1997). The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung. J. Pathol.181,401\u2013404.","DOI":"10.1002\/(SICI)1096-9896(199704)181:4<401::AID-PATH799>3.0.CO;2-Y"},{"key":"key\n\t\t\t\t20171013192915_BIB26","doi-asserted-by":"crossref","unstructured":"Cooper, C. A., Bubb, V. J., Smithson, N., Carter, R. L., Gledhill, S., Lamb, D., Wyllie, A. H., and Carey, F. A. (1996). Loss of heterozygosity at 5q21 in non-small cell lung cancer: A frequent event but without evidence of apc mutation. J. Pathol.180,33\u201337.","DOI":"10.1002\/(SICI)1096-9896(199609)180:1<33::AID-PATH642>3.0.CO;2-Y"},{"key":"key\n\t\t\t\t20171013192915_BIB27","doi-asserted-by":"crossref","unstructured":"Czene, K., Lichtenstein, P., and Hemminki, K. (2002). Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int. J. Cancer99,260\u2013266.","DOI":"10.1002\/ijc.10332"},{"key":"key\n\t\t\t\t20171013192915_BIB28","doi-asserted-by":"crossref","unstructured":"Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002). Mutations of the BRAF gene in human cancer. Nature417,949\u2013954.","DOI":"10.1038\/nature00766"},{"key":"key\n\t\t\t\t20171013192915_BIB29","unstructured":"De Benedetti, V. M., Welsh, J. A., Trivers, G. E., Harpster, A., Parkinson, A. J., Lanier, A. P., McMahon, B. J., and Bennett, W. P. (1995). p53 is not mutated in hepatocellular carcinomas from Alaska Natives. Cancer Epidemiol. Biomarkers Prev.4,79\u201382."},{"key":"key\n\t\t\t\t20171013192915_BIB30","unstructured":"Delclos, K. B., el-Bayoumy, K., Casciano, D. A., Walker, R. P., Kadlubar, F. F., Hecht, S. S., Shivapurkar, J., Mandal, S., and Stoner, G. D. (1989). Metabolic activation of 6-nitrochrysene in explants of human bronchus and in isolated rat hepatocytes. Cancer Res.49,2909\u20132913."},{"key":"key\n\t\t\t\t20171013192915_BIB31","doi-asserted-by":"crossref","unstructured":"Demokan, S., Demir, D., Suoglu, Y., Kiyak, E., Akar, U., and Dalay, N. (2005). Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer. Pathol. Oncol. Res.11,22\u201325.","DOI":"10.1007\/BF03032401"},{"key":"key\n\t\t\t\t20171013192915_BIB32","doi-asserted-by":"crossref","unstructured":"Deng, Z., Ma, Y., Pan, L., and Peng, H. (1997). A molecular epidemiologic marker of hepatocellular carcinoma from aflatoxin B1 contaminated area in the southwest of Guangxi. Chin. J. Cancer Res.9,167\u2013169.","DOI":"10.1007\/BF02953872"},{"key":"key\n\t\t\t\t20171013192915_BIB33","doi-asserted-by":"crossref","unstructured":"Devereux, T. R., Anderson, M. W., and Belinsky, S. A. (1991). Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Carcinogenesis12,299\u2013303.","DOI":"10.1093\/carcin\/12.2.299"},{"key":"key\n\t\t\t\t20171013192915_BIB34","doi-asserted-by":"crossref","unstructured":"Devereux, T. R., Belinsky, S. A., Maronpot, R. R., White, C. M., Hegi, M. E., Patel, A. C., Foley, J. F., Greenwell, A., and Anderson, M. W. (1993a). Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains. Mol. Carcinog.8,177\u2013185.","DOI":"10.1002\/mc.2940080308"},{"key":"key\n\t\t\t\t20171013192915_BIB35","doi-asserted-by":"crossref","unstructured":"Devereux, T. R., Foley, J. F., Maronpot, R. R., Kari, F., and Anderson, M. W. (1993b). Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride. Carcinogenesis14,795\u2013801.","DOI":"10.1093\/carcin\/14.5.795"},{"key":"key\n\t\t\t\t20171013192915_BIB36","doi-asserted-by":"crossref","unstructured":"Diamantis, I. D., McGandy, C., Chen, T. J., Liaw, Y. F., Gudat, F., and Bianchi, L. (1994). A new mutational hot-spot in the p53 gene in human hepatocellular carcinoma. J. Hepatol.20,553\u2013536.","DOI":"10.1016\/S0168-8278(05)80505-7"},{"key":"key\n\t\t\t\t20171013192915_BIB37","doi-asserted-by":"crossref","unstructured":"Doi, S. T., Kimura, M., and Katsuki, M. (1994). Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice. Jpn. J. Cancer Res.85,801\u2013807.","DOI":"10.1111\/j.1349-7006.1994.tb02951.x"},{"key":"key\n\t\t\t\t20171013192915_BIB38","doi-asserted-by":"crossref","unstructured":"Dote, H., Tsukuda, K., Toyooka, S., Yano, M., Pass, H. I., and Shimizu, N. (2004). Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP. Oncol. Reports11,361\u2013363.","DOI":"10.3892\/or.11.2.361"},{"key":"key\n\t\t\t\t20171013192915_BIB39","unstructured":"Dragani, T. A., Manenti, G., Colombo, B. M., Falvella, F. S., Gariboldi, M., Pierotti, M. A., and Della Porta, G. (1991). Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis. Oncogene6,333\u2013338."},{"key":"key\n\t\t\t\t20171013192915_BIB40","doi-asserted-by":"crossref","unstructured":"Efron, B., and Ribshirani, R. (1993). An Introduction to Bootstrap. Chapman and Hall, New York, NY.","DOI":"10.1007\/978-1-4899-4541-9"},{"key":"key\n\t\t\t\t20171013192915_BIB41","doi-asserted-by":"crossref","unstructured":"Enomoto, T., Weghorst, C. M., Ward, J. M., Anderson, L. M., Perantoni, A. O., and Rice, J. M. (1993). Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H\/HeNCr mice. Carcinogenesis14,1939\u20131944.","DOI":"10.1093\/carcin\/14.9.1939"},{"key":"key\n\t\t\t\t20171013192915_BIB42","doi-asserted-by":"crossref","unstructured":"Festing, M. F. W. (1995). Use of a multistrain assay could improve the NTP Carcinogenesis bioassay. Environ. Health. Persp.103,44\u201352.","DOI":"10.1289\/ehp.9510344"},{"key":"key\n\t\t\t\t20171013192915_BIB43","doi-asserted-by":"crossref","unstructured":"Festing, M. F. W., Lin, L., Devereux, T. R., et al. (1998). At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A\/J\u00d7Balb\/c mice. Genomics53,129\u2013136.","DOI":"10.1006\/geno.1998.5450"},{"key":"key\n\t\t\t\t20171013192915_BIB44","unstructured":"Fox, T. R., Schumann, A. M., Watanabe, P. G., Yano, B. L., Maher, V. M., and McCormick, J. J. (1990). Mutational analysis of the H-ras oncogene in spontaneous C57BL\/6 x C3H\/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res.50,4014\u20134019."},{"key":"key\n\t\t\t\t20171013192915_BIB45","doi-asserted-by":"crossref","unstructured":"Frey, S., Buchmann, A., Bursch, W., Schulte-Hermann, R., and Schwarz, M. (2000). Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene. Carcinogenesis21,161\u2013166.","DOI":"10.1093\/carcin\/21.2.161"},{"key":"key\n\t\t\t\t20171013192915_BIB46","unstructured":"Fujimoto, Y., Hampton, L. L., Wirth, P. J., Wang, N. J., Xie, J. P., and Thorgeirsson, S. S. (1994). Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res.54,281\u2013285."},{"key":"key\n\t\t\t\t20171013192915_BIB47","doi-asserted-by":"crossref","unstructured":"Goldblum, J. R., Bartos, R. E., Carr, K. A., and Frank, T. S. (1993). Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma. Am. J. Surg. Pathol.17,1244\u20131251.","DOI":"10.1097\/00000478-199312000-00005"},{"key":"key\n\t\t\t\t20171013192915_BIB48","doi-asserted-by":"crossref","unstructured":"Gotoh, J., Obata, M., Yoshie, M., Kasai, S., and Ogawa, K. (2003). Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1\/2 in mouse hepatic carcinogenesis. Carcinogenesis24,435\u2013442.","DOI":"10.1093\/carcin\/24.3.435"},{"key":"key\n\t\t\t\t20171013192915_BIB49","doi-asserted-by":"crossref","unstructured":"Gray, D. L., Warshawsky, D., Xue, W., Nines, R., Wang, Y., Yao, R., and Stoner, G. D. (2001). The effects of a binary mixture of benzo(a)pyrene and 7H-dibenzo(c,g)carbazole on lung tumors and K-ras oncogene mutations in strain A\/J mice. Exp. Lung Res.27,245\u2013253.","DOI":"10.1080\/019021401300054000"},{"key":"key\n\t\t\t\t20171013192915_BIB50","unstructured":"Greenblatt, M. S., Feitelson, M. A., Zhu, M., Bennett, W. P., Welsh, J. A., Jones, R., Borkowski, A., and Harris, C. C. (1997). Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas. Cancer Res.57,426\u2013432."},{"key":"key\n\t\t\t\t20171013192915_BIB51","doi-asserted-by":"crossref","unstructured":"Hayashi, H., Sugio, K., Matsumata, T., Adachi, E., Urata, K., Tanaka, S., and Sugimachi, K. (1993). The mutation of codon 249 in the p53 gene is not specific in Japanese hepatocellular carcinoma. Liver13,279\u2013281.","DOI":"10.1111\/j.1600-0676.1993.tb00645.x"},{"key":"key\n\t\t\t\t20171013192915_BIB52","doi-asserted-by":"crossref","unstructured":"Hayashi, I., Konishi, N., Matsuda, H., Tsuzuki, T., Tao, M., Kitahori, Y., Tokuyama, T., Yoneda, T., Narita, N., and Hiass, Y. (1996). Comparative analysis of p16\/CDKN2, p53 and ras gene alterations in human non-small cell lung cancers, with and without associated pulmonary asbestosis. Internat. J. Oncol.8,85\u201390.","DOI":"10.3892\/ijo.8.1.85"},{"key":"key\n\t\t\t\t20171013192915_BIB53","doi-asserted-by":"crossref","unstructured":"Hayashi, S., Hong, H. H., Toyoda, K., Ton, T. V., Devereux, T. R., Maronpot, R. R., Huff, J., and Sills, R. C. (2001). High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years. Toxicol. Pathol.29,422\u2013429.","DOI":"10.1080\/01926230152499908"},{"key":"key\n\t\t\t\t20171013192915_BIB54","doi-asserted-by":"crossref","unstructured":"Hayashi, S. M., Ton, T. V., Hong, H. H., Irwin, R. D., Haseman, J. K., Devereux, T. R., and Sills, R. C. (2003). Genetic alterations in the Catnb gene but not the H-ras gene in hepatocellular neoplasms and hepatoblastomas of B6C3F(1) mice following exposure to diethanolamine for 2 years. Chem. Biol. Interact.146,251\u2013261.","DOI":"10.1016\/j.cbi.2003.07.001"},{"key":"key\n\t\t\t\t20171013192915_BIB55","doi-asserted-by":"crossref","unstructured":"Hegi, M. E., Soderkvist, P., Foley, J. F., Schoonhoven, R., Swenberg, J. A., Kari, F., Maronpot, R., Anderson, M. W., and Wiseman, R. W. (1993). Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis14,803\u2013810.","DOI":"10.1093\/carcin\/14.5.803"},{"key":"key\n\t\t\t\t20171013192915_BIB56","doi-asserted-by":"crossref","unstructured":"Hermeking, H. (2003). Serial analysis of gene expression and cancer. Curr. Opin. Oncol.15,44\u201349.","DOI":"10.1097\/00001622-200301000-00006"},{"key":"key\n\t\t\t\t20171013192915_BIB57","doi-asserted-by":"crossref","unstructured":"Herreno-Saenz, D., Evans, F. E., Beland, F. A., and Fu, P. P. (1995). Identification of two N2-deoxyguanosinyl DNA adducts upon nitroreduction of the environmental mutagen 1-nitropyrene. Chem. Res. Toxicol.8,269\u2013277.","DOI":"10.1021\/tx00044a600"},{"key":"key\n\t\t\t\t20171013192915_BIB58","doi-asserted-by":"crossref","unstructured":"Herzog, C. R., Schut, H. A., Maronpot, R. R., and You, M. (1993). ras mutations in 2-amino-3-methylimidazo-[4,5-f]quinoline-induced tumors in the CDF1 mouse. Mol. Carcinog.8,202\u2013207.","DOI":"10.1002\/mc.2940080311"},{"key":"key\n\t\t\t\t20171013192915_BIB59","doi-asserted-by":"crossref","unstructured":"Hollstein, M., Marion, M. J., Lehman, T., Welsh, J., Harris, C. C., Martel-Planche, G., Kusters, I., and Montesano, R. (1994). p53 Mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers. Carcinogenesis15,1\u20133.","DOI":"10.1093\/carcin\/15.1.1"},{"key":"key\n\t\t\t\t20171013192915_BIB60","doi-asserted-by":"crossref","unstructured":"Hollstein, M. C., Wild, C. P., Bleicher, F., Chutimataewin, S., Harris, C. C., Srivatanakul, P., and Montesano, R. (1993). p53 Mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int. J. Cancer53,51\u201355.","DOI":"10.1002\/ijc.2910530111"},{"key":"key\n\t\t\t\t20171013192915_BIB61","doi-asserted-by":"crossref","unstructured":"Hong, H. H., Devereux, T. R., Roycroft, J. H., Boorman, G. A., and Sills, R. C. (1998). Frequency of ras mutations in liver neoplasms from B6C3F1 mice exposed to tetrafluoroethylene for two years. Toxicol. Pathol.26,646\u2013650.","DOI":"10.1177\/019262339802600508"},{"key":"key\n\t\t\t\t20171013192915_BIB62","doi-asserted-by":"crossref","unstructured":"Hoque, A., Patt, Y. Z., Yoffe, B., Groopman, J. D., Greenblatt, M. S., Zhang, Y. J., and Santella, R. M. (1999). Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States? Nutr. Cancer35,27\u201333.","DOI":"10.1207\/S1532791427-33"},{"key":"key\n\t\t\t\t20171013192915_BIB63","unstructured":"Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Nagase, H., Ando, H., Yanagisawa, A., Tsuchiya, E., Kato, Y., and Nakamura, Y. (1992). Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res.52,6696\u20136698."},{"key":"key\n\t\t\t\t20171013192915_BIB64","doi-asserted-by":"crossref","unstructured":"Horio, Y., Chen, A., Rice, P., Roth, J. A., Malkinson, A. M., and Schrump, D. S. (1996). Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A\/J mice. Mol. Carcinog.17,217\u2013223.","DOI":"10.1002\/(SICI)1098-2744(199612)17:4<217::AID-MC5>3.0.CO;2-A"},{"key":"key\n\t\t\t\t20171013192915_BIB65","unstructured":"Hosono, S., Chou, M. J., Lee, C. S., and Shih, C. (1993). Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene8,491\u2013496."},{"key":"key\n\t\t\t\t20171013192915_BIB66","doi-asserted-by":"crossref","unstructured":"Hsia, C. C., Nakashima, Y., Thorgeirsson, S. S., Harris, C. C., Minemura, M., Momosaki, S., Wang, N. J., and Tabor, E. (2000). Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma. Oncol. Rep.7,353\u2013356.","DOI":"10.3892\/or.7.2.353"},{"key":"key\n\t\t\t\t20171013192915_BIB67","doi-asserted-by":"crossref","unstructured":"Hsieh, D. P., and Atkinson, D. N. (1995). Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: Lack of association. Food Addit. Contam.12,421\u2013424.","DOI":"10.1080\/02652039509374324"},{"key":"key\n\t\t\t\t20171013192915_BIB68","doi-asserted-by":"crossref","unstructured":"Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. (1991). Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature350,427\u2013428.","DOI":"10.1038\/350427a0"},{"key":"key\n\t\t\t\t20171013192915_BIB69","doi-asserted-by":"crossref","unstructured":"Huang, H., Ushijima, T., Nagao, M., Sugimura, T., and Ohgaki, H. (2003). Beta-catenin mutations in liver tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in CDF1 mice. Cancer Lett.198,29\u201335.","DOI":"10.1016\/S0304-3835(03)00273-8"},{"key":"key\n\t\t\t\t20171013192915_BIB70","doi-asserted-by":"crossref","unstructured":"Husgafvel-Pursiainen, K., Hackman, P., Ridanpaa, M., Anttila, S., Karjalainen, A., Partanen, T., Taikina-Aho, O., Heikkila, L., and Vainio, H. (1993). K-ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos. Int. J. Cancer53,250\u2013256.","DOI":"10.1002\/ijc.2910530213"},{"key":"key\n\t\t\t\t20171013192915_BIB72","doi-asserted-by":"crossref","unstructured":"Iida, M., Iwata, H., Inoue, H., Enomoto, M., Horie, N., and Takeishi, K. (2000). Correlation between Bcl-2 overexpression and H-ras mutation in naturally occurring hepatocellular proliferative lesions of the B6C3F1 mouse. Toxicol. Sci.56,297\u2013302.","DOI":"10.1093\/toxsci\/56.2.297"},{"key":"key\n\t\t\t\t20171013192915_BIB73","doi-asserted-by":"crossref","unstructured":"Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., and Thun, M. J. (2005). Cancer statistics, 2005. CA Cancer J. Clin.55,10\u201330.","DOI":"10.3322\/canjclin.55.1.10"},{"key":"key\n\t\t\t\t20171013192915_BIB74","doi-asserted-by":"crossref","unstructured":"Jin, Y., Abe, K., Sato, Y., Aita, K., Irie, H., and Shiga, J. (2002). Hepatitis B and C virus infection and p53 mutations in human hepatocellular carcinoma in Harbin, Heilongjian Province, China. Hepatol. Res.24,379\u2013384.","DOI":"10.1016\/S1386-6346(02)00135-3"},{"key":"key\n\t\t\t\t20171013192915_BIB75","doi-asserted-by":"crossref","unstructured":"Johansson, E., Reynolds, S., Anderson, M., and Maronpot, R. (1997). Frequency of Ha-ras-1 gene mutations inversely correlated with furan dose in mouse liver tumors. Mol. Carcinog.18,199\u2013205.","DOI":"10.1002\/(SICI)1098-2744(199704)18:4<199::AID-MC3>3.0.CO;2-9"},{"key":"key\n\t\t\t\t20171013192915_BIB76","doi-asserted-by":"crossref","unstructured":"Jones, P. A. (2005). Overview of cancer epigenetics. Semin. Hematol.42,S3\u2013S8.","DOI":"10.1053\/j.seminhematol.2005.05.001"},{"key":"key\n\t\t\t\t20171013192915_BIB77","doi-asserted-by":"crossref","unstructured":"Kalkuhl, A., Kaestner, K., Buchmann, A., and Schwarz, M. (1996). Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours. Carcinogenesis17,609\u2013612.","DOI":"10.1093\/carcin\/17.3.609"},{"key":"key\n\t\t\t\t20171013192915_BIB78","doi-asserted-by":"crossref","unstructured":"Kalkuhl, A., Troppmair, J., Buchmann, A., Stinchcombe, S., Buenemann, C. L., Rapp, U. R., Kaestner, K., and Schwarz, M. (1998). p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions. Hepatology27,1081\u20131088.","DOI":"10.1002\/hep.510270425"},{"key":"key\n\t\t\t\t20171013192915_BIB79","doi-asserted-by":"crossref","unstructured":"Kar, S., Jaffe, R., and Carr, B. I. (1993). Mutation at codon 249 of p53 gene in a human hepatoblastoma. Hepatology18,566\u2013569.","DOI":"10.1002\/hep.1840180314"},{"key":"key\n\t\t\t\t20171013192915_BIB80","doi-asserted-by":"crossref","unstructured":"Karachristos, A., Liloglou, T., Field, J. K., Deligiorgi, E., Kouskouni, E., and Spandidos, D. A. (1999). Microsatellite instability and p53 mutations in hepatocellular carcinoma. Mol. Cell. Biol. Res. Commun.2,155\u2013161.","DOI":"10.1006\/mcbr.1999.0170"},{"key":"key\n\t\t\t\t20171013192915_BIB81","doi-asserted-by":"crossref","unstructured":"Karasaki, H., Obata, M., Ogawa, K., and Lee, G. H. (1997). Roles of the Pas1 and Par2 genes in determination of the unique, intermediate susceptibility of BALB\/cByJ mice to urethane-induction of lung carcinogenesis: Differential effects on tumor multiplicity, size and Kras2 mutations. Oncogene15,1833\u20131840.","DOI":"10.1038\/sj.onc.1201357"},{"key":"key\n\t\t\t\t20171013192915_BIB82","doi-asserted-by":"crossref","unstructured":"Katiyar, S., Dash, B. C., Thakur, V., Guptan, R. C., Sarin, S. K., and Das, B. C. (2000). p53 Tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer88,1565\u20131573.","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1565::AID-CNCR10>3.0.CO;2-9"},{"key":"key\n\t\t\t\t20171013192915_BIB83","doi-asserted-by":"crossref","unstructured":"Kawano, R., Nishisaka, T., Takeshima, Y., Yonehara, S., and Inai, K. (1995). Role of point mutation of the K-ras gene in tumorigenesis of B6C3F1 mouse lung lesions induced by urethane. Jpn. J. Cancer Res.86,802\u2013810.","DOI":"10.1111\/j.1349-7006.1995.tb03089.x"},{"key":"key\n\t\t\t\t20171013192915_BIB84","doi-asserted-by":"crossref","unstructured":"Kawano, R., Takeshima, Y., and Inai, K. (1996). Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A\/J mice. Jpn. J. Cancer Res.87,44\u201350.","DOI":"10.1111\/j.1349-7006.1996.tb00198.x"},{"key":"key\n\t\t\t\t20171013192915_BIB85","doi-asserted-by":"crossref","unstructured":"Kazachkov, Y., Khaoustov, V., Yoffe, B., Solomon, H., Klintmalm, G. B., and Tabor, E. (1996). p53 Abnormalities in hepatocellular carcinoma from United States patients: Analysis of all 11 exons. Carcinogenesis17,2207\u20132212.","DOI":"10.1093\/carcin\/17.10.2207"},{"key":"key\n\t\t\t\t20171013192915_BIB86","doi-asserted-by":"crossref","unstructured":"Kennedy, S. M., Macgeogh, C., Jaffe, R., and Spurr, N. K. (1994). Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum. Pathol.25,438\u2013442.","DOI":"10.1016\/0046-8177(94)90114-7"},{"key":"key\n\t\t\t\t20171013192915_BIB87","doi-asserted-by":"crossref","unstructured":"Keohavong, P., Mady, H. H., Gao, W. M., Siegfried, J. M., Luketich, J. D., and Melhem, M. F. (2001). Topographic analysis of K-ras mutations in histologically normal lung tissues and tumours of lung cancer patients. Br. J. Cancer85,235\u2013241.","DOI":"10.1054\/bjoc.2001.1913"},{"key":"key\n\t\t\t\t20171013192915_BIB88","doi-asserted-by":"crossref","unstructured":"Khoury, M. J., Davis, R., Gwinn, M., Lindegren, M. L., and Yoon, P. (2005). Do we need genomic research for prevention of common diseases w\/ environmental causes? Am. J. Epidemiol.161,799\u2013805.","DOI":"10.1093\/aje\/kwi113"},{"key":"key\n\t\t\t\t20171013192915_BIB89","unstructured":"Kishimoto, Y., Murakami, Y., Shiraishi, M., Hayashi, K., and Sekiya, T. (1992). Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res.52,4799\u20134804."},{"key":"key\n\t\t\t\t20171013192915_BIB90","doi-asserted-by":"crossref","unstructured":"Kitamura, F., Araki, S., Tanigawa, T., Miura, H., Akabane, H., and Iwasaki, R. (1998). Assessment of mutations of Ha- and Ki-ras oncogenes and the p53 suppressor gene in seven malignant mesothelioma patients exposed to asbestos\u2013PCR-SSCP and sequencing analyses of paraffin-embedded primary tumors. Ind. Health36,52\u201356.","DOI":"10.2486\/indhealth.36.52"},{"key":"key\n\t\t\t\t20171013192915_BIB91","unstructured":"Kress, S., Jahn, U. R., Buchmann, A., Bannasch, P., and Schwarz, M. (1992). p53 Mutations in human hepatocellular carcinomas from Germany. Cancer Res.52,3220\u20133223."},{"key":"key\n\t\t\t\t20171013192915_BIB92","doi-asserted-by":"crossref","unstructured":"Kubicka, S., Trautwein, C., Schrem, H., Tillmann, H., and Manns, M. (1995). Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event. J. Hepatol.23,412\u2013419.","DOI":"10.1016\/0168-8278(95)80199-5"},{"key":"key\n\t\t\t\t20171013192915_BIB93","unstructured":"Lai, M. Y., Chang, H. C., Li, H. P., Ku, C. K., Chen, P. J., Sheu, J. C., Huang, G. T., Lee, P. H., and Chen, D. S. (1993). Splicing mutations of the p53 gene in human hepatocellular carcinoma. Cancer Res.53,1653\u20131656."},{"key":"key\n\t\t\t\t20171013192915_BIB94","doi-asserted-by":"crossref","unstructured":"Laurent-Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac-Sage, P., and Zucman-Rossi, J. (2001). Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology120,1763\u20131773.","DOI":"10.1053\/gast.2001.24798"},{"key":"key\n\t\t\t\t20171013192915_BIB95","doi-asserted-by":"crossref","unstructured":"Lee, G. H., and Drinkwater, N. R. (1995). Hepatocarcinogenesis in BXH recombinant inbred strains of mice: Analysis of diverse phenotypic effects of the hepatocarcinogen sensitivity loci. Mol. Carcinog.14,190\u2013197.","DOI":"10.1002\/mc.2940140308"},{"key":"key\n\t\t\t\t20171013192915_BIB96","doi-asserted-by":"crossref","unstructured":"Lee, S. J., Lee, S. Y., Jeon, H. S., Park, S. H., Jang, J. S., Lee, G. Y., Son, J. W., Kim, C. H., Lee, W. K., Kam, S., et al. (2005). Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol. Biomarkers Prev.14,571\u2013575.","DOI":"10.1158\/1055-9965.EPI-04-0472"},{"key":"key\n\t\t\t\t20171013192915_BIB97","doi-asserted-by":"crossref","unstructured":"Lee, S. N., Park, C. K., Sung, C. O., Choi, J. S., Oh, Y. L., Cho, J. W., and Yoo, B. C. (2002). Correlation of mutation and immunohistochemistry of p53 in hepatocellular carcinomas in Korean people. J. Korean Med. Sci.17,801\u2013805.","DOI":"10.3346\/jkms.2002.17.6.801"},{"key":"key\n\t\t\t\t20171013192915_BIB98","doi-asserted-by":"crossref","unstructured":"Li, D., Cao, Y., He, L., Wang, N. J., and Gu, J. R. (1993). Aberrations of p53 gene in human hepatocellular carcinoma from China. Carcinogenesis14,169\u2013173.","DOI":"10.1093\/carcin\/14.2.169"},{"key":"key\n\t\t\t\t20171013192915_BIB99","doi-asserted-by":"crossref","unstructured":"Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., and Hemminki, K. (2000). Environmental and heritable factors in the causation of cancer\u2014analyses of cohorts of twins from Sweden, Denmark, and Finland. New Engl. J. Med.343,78\u201385.","DOI":"10.1056\/NEJM200007133430201"},{"key":"key\n\t\t\t\t20171013192915_BIB100","doi-asserted-by":"crossref","unstructured":"Lin, L., Festing, M. F., Devereux, T. R., Crist, K. A., Christiansen, S. C., Wang, Y., Yang, A., Svenson, K., Paigen, B., Malkinson, A. M., et al. (1998). Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp. Lung Res.24,481\u2013497.","DOI":"10.3109\/01902149809087382"},{"key":"key\n\t\t\t\t20171013192915_BIB101","doi-asserted-by":"crossref","unstructured":"Lord, P. G., Hardaker, K. J., Loughlin, J. M., Marsden, A. M., and Orton, T. C. (1992). Point mutation analysis of ras genes in spontaneous and chemically induced C57Bl\/10J mouse liver tumours. Carcinogenesis13,1383\u20131387.","DOI":"10.1093\/carcin\/13.8.1383"},{"key":"key\n\t\t\t\t20171013192915_BIB102","unstructured":"Lunn, R. M., Zhang, Y. J., Wang, L. Y., Chen, C. J., Lee, P. H., Lee, C. S., Tsai, W. Y., and Santella, R. M. (1997). p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res.57,3471\u20133477."},{"key":"key\n\t\t\t\t20171013192915_BIB103","doi-asserted-by":"crossref","unstructured":"Maeshima, A., Miyagi, A., Hirai, T., and Nakajima, T. (1997). Mucin-producing adenocarcinoma of the lung, with special reference to goblet cell type adenocarcinoma: Immunohistochemical observation and Ki-ras gene mutation. Pathol. Int.47,454\u2013460.","DOI":"10.1111\/j.1440-1827.1997.tb04524.x"},{"key":"key\n\t\t\t\t20171013192915_BIB104","doi-asserted-by":"crossref","unstructured":"Maeshima, A., Sakamoto, M., and Hirohashi, S. (2002). Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: Immunohistochemical examination and K-ras gene mutation. Virchows Arch.440,598\u2013603.","DOI":"10.1007\/s00428-002-0629-6"},{"key":"key\n\t\t\t\t20171013192915_BIB105","doi-asserted-by":"crossref","unstructured":"Malarkey, D. E., Devereux, T. R., Dinse, G. E., Mann, P. C., and Maronpot, R. R. (1995). Hepatocarcinogenicity of chlordane in B6C3F1 and B6D2F1 male mice: Evidence for regression in B6C3F1 mice and carcinogenesis independent of ras proto-oncogene activation. Carcinogenesis16,2617\u20132625.","DOI":"10.1093\/carcin\/16.11.2617"},{"key":"key\n\t\t\t\t20171013192915_BIB106","doi-asserted-by":"crossref","unstructured":"Manam, S., Shinder, G. A., Joslyn, D. J., Kraynak, A. R., Hammermeister, C. L., Leander, K. R., Ledwith, B. J., Prahalada, S., van Zwieten, M. J., and Nichols, W. W. (1995). Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors. Carcinogenesis16,1113\u20131119.","DOI":"10.1093\/carcin\/16.5.1113"},{"key":"key\n\t\t\t\t20171013192915_BIB107","doi-asserted-by":"crossref","unstructured":"Manam, S., Storer, R. D., Prahalada, S., Leander, K. R., Kraynak, A. R., Hammermeister, C. L., Joslyn, D. J., Ledwith, B. J., van Zwieten, M. J., Bradley, M. O., et al. (1992a). Activation of the Ki-ras gene in spontaneous and chemically induced lung tumors in CD-1 mice. Mol. Carcinog.6,68\u201375.","DOI":"10.1002\/mc.2940060111"},{"key":"key\n\t\t\t\t20171013192915_BIB108","doi-asserted-by":"crossref","unstructured":"Manam, S., Storer, R. D., Prahalada, S., Leander, K. R., Kraynak, A. R., Ledwith, B. J., van Zwieten, M. J., Bradley, M. O., and Nichols, W. W. (1992b). Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice. Cancer Res.52,3347\u20133352.","DOI":"10.1002\/mc.2940060111"},{"key":"key\n\t\t\t\t20171013192915_BIB109","doi-asserted-by":"crossref","unstructured":"Manenti, G., Falvella, F. S., Gariboldi, M., Dragani, T. A., and Pierotti, M. A. (1995). Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2. Genomics29,438\u2013444.","DOI":"10.1006\/geno.1995.9984"},{"key":"key\n\t\t\t\t20171013192915_BIB110","doi-asserted-by":"crossref","unstructured":"Manjanatha, M. G., Li, E. E., Fu, P. P., and Heflich, R. H. (1996). H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice. J. Toxicol. Environ. Health.47,195\u2013208.","DOI":"10.1080\/009841096161898"},{"key":"key\n\t\t\t\t20171013192915_BIB111","unstructured":"Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M., and Sidransky, D. (1994). Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res.54,1634\u20131637."},{"key":"key\n\t\t\t\t20171013192915_BIB112","doi-asserted-by":"crossref","unstructured":"Maronpot, R. R., Fox, T., Malarkey, D. E., and Goldsworthy, T. (1995). Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology101,125\u2013156.","DOI":"10.1016\/0300-483X(95)03112-S"},{"key":"key\n\t\t\t\t20171013192915_BIB113","doi-asserted-by":"crossref","unstructured":"Mass, M. J., Abu-Shakra, A., Roop, B. C., Nelson, G., Galati, A. J., Stoner, G. D., Nesnow, S., and Ross, J. A. (1996). Benzo[b]fluoranthene: Tumorigenicity in strain A\/J mouse lungs, DNA adducts and mutations in the Ki-ras oncogene. Carcinogenesis17,1701\u20131704.","DOI":"10.1093\/carcin\/17.8.1701"},{"key":"key\n\t\t\t\t20171013192915_BIB114","doi-asserted-by":"crossref","unstructured":"Mass, M. J., Jeffers, A. J., Ross, J. A., Nelson, G., Galati, A. J., Stoner, G. D., and Nesnow, S. (1993). Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A\/J mice. Mol. Carcinog.8,186\u2013192.","DOI":"10.1002\/mc.2940080309"},{"key":"key\n\t\t\t\t20171013192915_BIB115","doi-asserted-by":"crossref","unstructured":"Massey, T. E., Devereux, T. R., Maronpot, R. R., Foley, J. F., and Anderson, M. W. (1995). High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL\/6J x BALB\/cJ) mice. Carcinogenesis16,1065\u20131069.","DOI":"10.1093\/carcin\/16.5.1065"},{"key":"key\n\t\t\t\t20171013192915_BIB116","doi-asserted-by":"crossref","unstructured":"Matzinger, S. A., Crist, K. A., Stoner, G. D., Anderson, M. W., Pereira, M. A., Steele, V. E., Kelloff, G. J., Lubet, R. A., and You, M. (1995). K-ras mutations in lung tumors from A\/J and A\/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis16,2487\u20132492.","DOI":"10.1093\/carcin\/16.10.2487"},{"key":"key\n\t\t\t\t20171013192915_BIB117","doi-asserted-by":"crossref","unstructured":"Matzinger, S. A., Gunning, W. T., You, M., and Castonguay, A. (1994). Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone- initiated and butylated hydroxytoluene-promoted lung tumors in A\/J mice. Mol. Carcinog.11,42\u201348.","DOI":"10.1002\/mc.2940110108"},{"key":"key\n\t\t\t\t20171013192915_BIB118","unstructured":"McCullagh, P., and Nelder, J. (1997). Generalized Linear Models. Chapman and Hall, New York, NY."},{"key":"key\n\t\t\t\t20171013192915_BIB119","unstructured":"Miller, C. W., Simon, K., Aslo, A., Kok, K., Yokota, J., Buys, C. H., Terada, M., and Koeffler, H. P. (1992). p53 mutations in human lung tumors. Cancer Res.52,1695\u20131698."},{"key":"key\n\t\t\t\t20171013192915_BIB120","doi-asserted-by":"crossref","unstructured":"Mitchell, K. R., and Warshawsky, D. (1999). Frequent Ha-ras mutations in murine skin and liver tumors induced by 7H-dibenzo[c,g]carbazole. Mol. Carcinog.25,107\u2013112.","DOI":"10.1002\/(SICI)1098-2744(199906)25:2<107::AID-MC5>3.0.CO;2-F"},{"key":"key\n\t\t\t\t20171013192915_BIB121","doi-asserted-by":"crossref","unstructured":"Mitsudomi, T., Lam, S., Shirakusa, T., and Gazdar, A. F. (1993). Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer. Chest104,362\u2013365.","DOI":"10.1378\/chest.104.2.362"},{"key":"key\n\t\t\t\t20171013192915_BIB122","doi-asserted-by":"crossref","unstructured":"Mor, O., Yaron, P., Huszar, M., Yellin, A., Jakobovitz, O., Brok-Simoni, F., Rechavi, G., and Reichert, N. (1997). Absence of p53 mutations in malignant mesotheliomas. Am. J. Respir. Cell Mol. Biol.16,9\u201313.","DOI":"10.1165\/ajrcmb.16.1.8998073"},{"key":"key\n\t\t\t\t20171013192915_BIB123","doi-asserted-by":"crossref","unstructured":"Mori, I., Hayashi, S., Horinouchi, A., Nonoyama, T., and Miyajima, H. (1995). Point mutations at codon 61 of the c-H-RAS gene detected in paraffin sections of spontaneous hepatocellular tumors in aged B6C3F1 mice. J. Toxicol. Pathol.8,123\u2013128.","DOI":"10.1293\/tox.8.123"},{"key":"key\n\t\t\t\t20171013192915_BIB124","unstructured":"Murakami, Y., Hayashi, K., Hirohashi, S., and Sekiya, T. (1991). Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res.51,5520\u20135525."},{"key":"key\n\t\t\t\t20171013192915_BIB125","doi-asserted-by":"crossref","unstructured":"Naito, M., Satake, M., Sakai, E., Hirano, Y., Tsuchida, N., Kanzaki, H., Ito, Y., and Mori, T. (1992). Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis. Jpn. J. Cancer Res.83,1030\u20131036.","DOI":"10.1111\/j.1349-7006.1992.tb02717.x"},{"key":"key\n\t\t\t\t20171013192915_BIB126","unstructured":"Naoki, K., Chen, T. H., Richards, W. G., Sugarbaker, D. J., and Meyerson, M. (2002). Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res.62,7001\u20137003."},{"key":"key\n\t\t\t\t20171013192915_BIB127","unstructured":"Nelson, H. H., Christiani, D. C., Wiencke, J. K., Mark, E. J., Wain, J. C., and Kelsey, K. T. (1999). K-ras mutation and occupational asbestos exposure in lung adenocarcinoma: Asbestos-related cancer without asbestosis. Cancer Res.59,4570\u20134573."},{"key":"key\n\t\t\t\t20171013192915_BIB128","doi-asserted-by":"crossref","unstructured":"Nesnow, S., Ross, J. A., Nelson, G., Wilson, K., Roop, B. C., Jeffers, A. J., Galati, A. J., Stoner, G. D., Sangaiah, R., Gold, A., et al. (1994). Cyclopenta[cd]pyrene-induced tumorigenicity, Ki-ras codon 12 mutations and DNA adducts in strain A\/J mouse lung. Carcinogenesis15,601\u2013606.","DOI":"10.1093\/carcin\/15.4.601"},{"key":"key\n\t\t\t\t20171013192915_BIB129","unstructured":"Ng, I. O., Chung, L. P., Tsang, S. W., Lam, C. L., Lai, E. C., Fan, S. T., and Ng, M. (1994a). p53 Gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene9,985\u2013990."},{"key":"key\n\t\t\t\t20171013192915_BIB130","doi-asserted-by":"crossref","unstructured":"Ng, I. O., Srivastava, G., Chung, L. P., Tsang, S. W., and Ng, M. M. (1994b). Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer74,30\u201337.","DOI":"10.1002\/1097-0142(19940701)74:1<30::AID-CNCR2820740107>3.0.CO;2-4"},{"key":"key\n\t\t\t\t20171013192915_BIB131","doi-asserted-by":"crossref","unstructured":"Ni, Z., Liu, Y., Keshava, N., Zhou, G., Whong, W., and Ong, T. (2000). Analysis of K-ras and p53 mutations in mesotheliomas from humans and rats exposed to asbestos. Mutat. Res.468,87\u201392.","DOI":"10.1016\/S1383-5718(00)00043-7"},{"key":"key\n\t\t\t\t20171013192915_BIB132","unstructured":"Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., and Ishizaki, K. (1993). Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res.53,368\u2013372."},{"key":"key\n\t\t\t\t20171013192915_BIB133","doi-asserted-by":"crossref","unstructured":"Nose, H., Imazeki, F., Ohto, M., and Omata, M. (1993). p53 Gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer72,355\u2013360.","DOI":"10.1002\/1097-0142(19930715)72:2<355::AID-CNCR2820720208>3.0.CO;2-W"},{"key":"key\n\t\t\t\t20171013192915_BIB134","doi-asserted-by":"crossref","unstructured":"Nuzum, E. O., Malkinson, A. M., and Beer, D. G. (1990). Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas. Mol. Carcinog.3,287\u2013295.","DOI":"10.1002\/mc.2940030509"},{"key":"key\n\t\t\t\t20171013192915_BIB135","unstructured":"Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., and Hirohashi, S. (1992a). p53 Gene mutation spectrum in hepatocellular carcinoma. Cancer Res.52,6358\u20136364."},{"key":"key\n\t\t\t\t20171013192915_BIB136","unstructured":"Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., and Hirohashi, S. (1992b). Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res.52,3674\u20133678."},{"key":"key\n\t\t\t\t20171013192915_BIB137","unstructured":"Ogawa, K., Yamada, Y., Kishibe, K., Ishizaki, K., and Tokusashi, Y. (1999). Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice. Cancer Res.59,1830\u20131833."},{"key":"key\n\t\t\t\t20171013192915_BIB138","doi-asserted-by":"crossref","unstructured":"Ohmori, H., Abe, T., Hirano, H., Murakami, T., Katoh, T., Gotoh, S., Kido, M., Kuroiwa, A., Nomura, T., and Higashi, K. (1992). Comparison of Ki-ras gene mutation among simultaneously occurring multiple urethan-induced lung tumors in individual mice. Carcinogenesis13,851\u2013855.","DOI":"10.1093\/carcin\/13.5.851"},{"key":"key\n\t\t\t\t20171013192915_BIB139","doi-asserted-by":"crossref","unstructured":"Olivier, M., Eeles, R., Hollstein, M., Khan, M. A., Harris, C. C., and Hainaut, P. (2002). The IARC TP53 database: New online mutation analysis and recommendations to users. Hum. Mutat.19,607\u2013614.","DOI":"10.1002\/humu.10081"},{"key":"key\n\t\t\t\t20171013192915_BIB140","doi-asserted-by":"crossref","unstructured":"Oreffo, V. I., Robinson, S., You, M., Wu, M. C., and Malkinson, A. M. (1998). Decreased expression of the adenomatous polyposis coli (Apc) and mutated in colorectal cancer (Mcc) genes in mouse lung neoplasia. Mol. Carcinogen.21,37\u201349.","DOI":"10.1002\/(SICI)1098-2744(199801)21:1<37::AID-MC6>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20171013192915_BIB141","unstructured":"Ozturk, M. (1991). p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet338,1356\u20131359."},{"key":"key\n\t\t\t\t20171013192915_BIB142","doi-asserted-by":"crossref","unstructured":"Pan, H., Califano, J., Ponte, J. F., et al. (2005). Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer. Cancer Res.65,1664\u20131669.","DOI":"10.1158\/0008-5472.CAN-04-3297"},{"key":"key\n\t\t\t\t20171013192915_BIB143","doi-asserted-by":"crossref","unstructured":"Park, Y. M., Yoo, Y. D., Han, K. H., Chun, J. Y., Kang, J. K., and Park, I. S. (1996). Mutation of tumor suppressor gene p53 in hepatocellular carcinomas from Korea. Exp. Mol. Med.28,173\u2013179.","DOI":"10.1038\/emm.1996.27"},{"key":"key\n\t\t\t\t20171013192915_BIB144","doi-asserted-by":"crossref","unstructured":"Philips, D. H., Hewer, A., Osborne, M. R., Cole, K. J., Churchill, C., and Arlt, V. M. (2005). Organ specificity of DNA adduct formation by tamoxifen and \u03b1-hydroxytamoxifen in the rat: Implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment. Mutagenesis20,297\u2013303.","DOI":"10.1093\/mutage\/gei038"},{"key":"key\n\t\t\t\t20171013192915_BIB145","doi-asserted-by":"crossref","unstructured":"Pogribny, I. P., and James, S. J. (2002). Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation. Cancer Lett.176,169\u2013174.","DOI":"10.1016\/S0304-3835(01)00748-0"},{"key":"key\n\t\t\t\t20171013192915_BIB146","doi-asserted-by":"crossref","unstructured":"Prahalad, A. K., Ross, J. A., Nelson, G. B., Roop, B. C., King, L. C., Nesnow, S., and Mass, M. J. (1997). Dibenzo+AFs-a,l+AF0-pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A\/J mouse lung. Carcinogenesis18,1955\u20131963.","DOI":"10.1093\/carcin\/18.10.1955"},{"key":"key\n\t\t\t\t20171013192915_BIB147","unstructured":"Prevo, L. J., Sanchez, C. A., Galipeau, P. C., and Reid, B. J. (1999). p53-mutant clones and field effects in Barrett's esophagus. Cancer Res.59,4784\u20134787."},{"key":"key\n\t\t\t\t20171013192915_BIB148","doi-asserted-by":"crossref","unstructured":"Ramakrishna, G., Bialkowska, A., Perella, C., Birely, L., Fornwald, L. W., Diwan, B. A., Shiao, Y. H., and Anderson, L. M. (2000). Ki-ras and the characteristics of mouse lung tumors. Mol. Carcinog.28,156\u2013167.","DOI":"10.1002\/1098-2744(200007)28:3<156::AID-MC4>3.0.CO;2-M"},{"key":"key\n\t\t\t\t20171013192915_BIB149","doi-asserted-by":"crossref","unstructured":"Ramakrishna, G., Perella, C., Birely, L., Diwan, B. A., Fornwald, L. W., and Anderson, L. M. (2002). Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol.179,21\u201334.","DOI":"10.1006\/taap.2001.9344"},{"key":"key\n\t\t\t\t20171013192915_BIB150","doi-asserted-by":"crossref","unstructured":"Rashid, A., Wang, J. S., Qian, G. S., Lu, B. X., Hamilton, S. R., and Groopman, J. D. (1999). Genetic alterations in hepatocellular carcinomas: Association between loss of chromosome 4q and p53 gene mutations. Br. J. Cancer80,59\u201366.","DOI":"10.1038\/sj.bjc.6690321"},{"key":"key\n\t\t\t\t20171013192915_BIB151","doi-asserted-by":"crossref","unstructured":"Re, F. C., Manenti, G., Borrello, M. G., Colombo, M. P., Fisher, J. H., Pierotti, M. A., Della Porta, G., and Dragani, T. A. (1992). Multiple molecular alterations in mouse lung tumors. Mol. Carcinog.5,155\u2013160.","DOI":"10.1002\/mc.2940050211"},{"key":"key\n\t\t\t\t20171013192915_BIB152","unstructured":"Redondo, M., Rodriguez, F., Hortas, M. L., Concha, A., Morell, M., Garrido, F., and Ruiz-Cabello, F. (1997). Lack of correlation between codon 12 K-ras mutations and major histocompatibility complex antigens in bronchogenic carcinomas. Cancer Detect. Prev.21,412\u2013417."},{"key":"key\n\t\t\t\t20171013192915_BIB153","doi-asserted-by":"crossref","unstructured":"Reichel, M. B., Ohgaki, H., Petersen, I., and Kleihues, P. (1994). p53 mutations in primary human lung tumors and their metastases. Mol. Carcinog.9,105\u2013109.","DOI":"10.1002\/mc.2940090208"},{"key":"key\n\t\t\t\t20171013192915_BIB154","doi-asserted-by":"crossref","unstructured":"Richardson, K. K., Helvering, L. M., Copple, D. M., Rexroat, M. A., Linville, D. W., Engelhardt, J. A., Todd, G. C., and Richardson, F. C. (1992a). Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986. Carcinogenesis13,935\u2013941.","DOI":"10.1093\/carcin\/13.6.935"},{"key":"key\n\t\t\t\t20171013192915_BIB155","doi-asserted-by":"crossref","unstructured":"Richardson, K. K., Rexroat, M. A., Helvering, L. M., Copple, D. M., and Richardson, F. C. (1992b). Temporal changes in the mutant frequency and mutation spectra of the 61st codon of the H-ras oncogene following exposure of B6C3F1 mice to N-nitrosodiethylamine (DEN). Carcinogenesis13,1277\u20131279.","DOI":"10.1093\/carcin\/13.7.1277"},{"key":"key\n\t\t\t\t20171013192915_BIB156","unstructured":"Rodenhuis, S., Slebos, R. J., Boot, A. J., Evers, S. G., Mooi, W. J., Wagenaar, S. S., van Bodegom, P. C., and Bos, J. L. (1988). Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res.48,5738\u20135741."},{"key":"key\n\t\t\t\t20171013192915_BIB157","doi-asserted-by":"crossref","unstructured":"Rodenhuis, S., van de Wetering, M. L., Mooi, W. J., Evers, S. G., van Zandwijk, N., and Bos, J. L. (1987). Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med.317,929\u2013935.","DOI":"10.1056\/NEJM198710083171504"},{"key":"key\n\t\t\t\t20171013192915_BIB158","doi-asserted-by":"crossref","unstructured":"Ronai, Z. A., Gradia, S., Peterson, L. A., and Hecht, S. S. (1993). G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis14,2419\u20132422.","DOI":"10.1093\/carcin\/14.11.2419"},{"key":"key\n\t\t\t\t20171013192915_BIB159","doi-asserted-by":"crossref","unstructured":"Rumsby, P. C., Barrass, N. C., Phillimore, H. E., and Evans, J. G. (1991). Analysis of the Ha-ras oncogene in C3H\/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Carcinogenesis12,2331\u20132336.","DOI":"10.1093\/carcin\/12.12.2331"},{"key":"key\n\t\t\t\t20171013192915_BIB160","unstructured":"Sahoo, T., Ramakrishna, B., Habibullah, C. M., Patil, D. N., and Das, M. R. (1993). p53 Mutation in human hepatocellular carcinoma in India. Curr. Sci. (Bangalore)65,554\u2013557."},{"key":"key\n\t\t\t\t20171013192915_BIB161","unstructured":"Sameshima, Y., Matsuno, Y., Hirohashi, S., Shimosato, Y., Mizoguchi, H., Sugimura, T., Terada, M., and Yokota, J. (1992). Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene7,451\u2013457."},{"key":"key\n\t\t\t\t20171013192915_BIB162","doi-asserted-by":"crossref","unstructured":"Sanchez-Cespedes, M., Reed, A. L., Buta, M., Wu, L., Westra, W. H., Herman, J. G., Yang, S. C., Jen, J., and Sidransky, D. (1999). Inactivation of the INK4A\/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene18,5843\u20135849.","DOI":"10.1038\/sj.onc.1203003"},{"key":"key\n\t\t\t\t20171013192915_BIB163","doi-asserted-by":"crossref","unstructured":"Schroeder, M., DeAngelo, A. B., and Mass, M. J. (1997). Dichloroacetic acid reduces Ha-ras codon 61 mutations in liver tumors from female B6C3F1 mice. Carcinogenesis18,1675\u20131678.","DOI":"10.1093\/carcin\/18.8.1675"},{"key":"key\n\t\t\t\t20171013192915_BIB164","unstructured":"Scorsone, K. A., Zhou, Y. Z., Butel, J. S., and Slagle, B. L. (1992). p53 Mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res.52,1635\u20131638."},{"key":"key\n\t\t\t\t20171013192915_BIB165","doi-asserted-by":"crossref","unstructured":"Segers, K., Backhovens, H., Singh, S. K., De Voecht, J., Ramael, M., Van Broeckhoven, C., and Van Marck, E. (1995). Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma. Virchows Arch.427,431\u2013436.","DOI":"10.1007\/BF00199393"},{"key":"key\n\t\t\t\t20171013192915_BIB166","unstructured":"Sheu, J. C., Huang, G. T., Lee, P. H., Chung, J. C., Chou, H. C., Lai, M. Y., Wang, J. T., Lee, H. S., Shih, L. N., Yang, P. M., et al. (1992). Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res.52,6098\u20136100."},{"key":"key\n\t\t\t\t20171013192915_BIB167","doi-asserted-by":"crossref","unstructured":"Shi, C. Y., Phang, T. W., Lin, Y., Wee, A., Li, B., Lee, H. P., and Ong, C. N. (1995). Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore. Br. J. Cancer72,146\u2013149.","DOI":"10.1038\/bjc.1995.291"},{"key":"key\n\t\t\t\t20171013192915_BIB168","doi-asserted-by":"crossref","unstructured":"Shieh, Y. S., Nguyen, C., Vocal, M. V., and Chu, H. W. (1993). Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Int. J. Cancer54,558\u2013562.","DOI":"10.1002\/ijc.2910540407"},{"key":"key\n\t\t\t\t20171013192915_BIB169","doi-asserted-by":"crossref","unstructured":"Shimizu, Y., Zhu, J. J., Han, F., Ishikawa, T., and Oda, H. (1999). Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China. Int. J. Cancer82,187\u2013190.","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<187::AID-IJC6>3.0.CO;2-1"},{"key":"key\n\t\t\t\t20171013192915_BIB170","doi-asserted-by":"crossref","unstructured":"Shinder, G. A., Manam, S., and Nichols, W. W. (1993). A sensitive restriction fragment length polymorphism method to detect CAA\u2192AAA mutations at codon 61 of Ha-ras. Mol. Carcinog.7,263\u2013267.","DOI":"10.1002\/mc.2940070409"},{"key":"key\n\t\t\t\t20171013192915_BIB171","unstructured":"Siegfried, J. M., Gillespie, A. T., Mera, R., Casey, T. J., Keohavong, P., Testa, J. R., and Hunt, J. D. (1997). Prognostic value of specific KRAS mutations in lung adenocarcinomas. Cancer Epidemiol. Biomarkers Prev.6,841\u2013847."},{"key":"key\n\t\t\t\t20171013192915_BIB172","doi-asserted-by":"crossref","unstructured":"Silini, E. M., Bosi, F., Pellegata, N. S., Volpato, G., Romano, A., Nazari, S., Tinelli, C., Ranzani, G. N., Solcia, E., and Fiocca, R. (1994). K-ras gene mutations: An unfavorable prognostic marker in stage I lung adenocarcinoma. Virchows Arch.424,367\u2013373.","DOI":"10.1007\/BF00190558"},{"key":"key\n\t\t\t\t20171013192915_BIB173","doi-asserted-by":"crossref","unstructured":"Sills, R. C., Hong, H. L., Greenwell, A., Herbert, R. A., Boorman, G. A., and Devereux, T. R. (1995). Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months. Carcinogenesis16,1623\u20131628.","DOI":"10.1093\/carcin\/16.7.1623"},{"key":"key\n\t\t\t\t20171013192915_BIB174","doi-asserted-by":"crossref","unstructured":"Sills, R. C., Hong, H. L., Melnick, R. L., Boorman, G. A., and Devereux, T. R. (1999). High frequency of codon 61 K-ras A-->T transversions in lung and Harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis20,657\u2013662.","DOI":"10.1093\/carcin\/20.4.657"},{"key":"key\n\t\t\t\t20171013192915_BIB175","doi-asserted-by":"crossref","unstructured":"Slaughter, D. P., Southwick, H. W., and Smejkal, W. (1953). \u201cField cancerization\u201d in oral stratified squamous epithelium. Cancer6,963\u2013968.","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q"},{"key":"key\n\t\t\t\t20171013192915_BIB176","doi-asserted-by":"crossref","unstructured":"Slebos, R. J., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J., Wagenaar, S. S., Vanderschueren, R. G., van Zandwijk, N., Mooi, W. J., et al. (1990). K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med.323,561\u2013565.","DOI":"10.1056\/NEJM199008303230902"},{"key":"key\n\t\t\t\t20171013192915_BIB177","doi-asserted-by":"crossref","unstructured":"Soini, Y., Chia, S. C., Bennett, W. P., Groopman, J. D., Wang, J. S., DeBenedetti, V. M., Cawley, H., Welsh, J. A., Hansen, C., Bergasa, N. V., et al. (1996). An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis17,1007\u20131012.","DOI":"10.1093\/carcin\/17.5.1007"},{"key":"key\n\t\t\t\t20171013192915_BIB178","doi-asserted-by":"crossref","unstructured":"Somers, V. A., Leimbach, D. A., Theunissen, P. H., Murtagh, J. J. J., Holloway, B., Ambergen, A. W., and Thunnissen, F. B. (1998). Validation of the Point-EXACCT method in non-small cell lung carcinomas. Clin. Chem.44,1404\u20131409.","DOI":"10.1093\/clinchem\/44.7.1404"},{"key":"key\n\t\t\t\t20171013192915_BIB179","doi-asserted-by":"crossref","unstructured":"Stanley, L. A., Devereux, T. R., Foley, J., Lord, P. G., Maronpot, R. R., Orton, T. C., and Anderson, M. W. (1992). Proto-oncogene activation in liver tumors of hepatocarcinogenesis- resistant strains of mice. Carcinogenesis13,2427\u20132433.","DOI":"10.1093\/carcin\/13.12.2427"},{"key":"key\n\t\t\t\t20171013192915_BIB180","unstructured":"Stern, M. C., Umbach, D. M., Yu, M. C., London, S. J., Zhang, Z. Q., and Taylor, J. A. (2001). Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol. Biomarkers Prev.10,617\u2013625."},{"key":"key\n\t\t\t\t20171013192915_BIB181","doi-asserted-by":"crossref","unstructured":"Stern, R. S., Bolshakov, S., Nataraj, A. J., and Ananthaswamy, H. N. (2002). p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: Evidence for heterogeneity and field cancerization. J. Investig. Dermatol.119,522\u2013526.","DOI":"10.1046\/j.1523-1747.2002.01814.x"},{"key":"key\n\t\t\t\t20171013192915_BIB182","unstructured":"Stowers, S. J., Glover, P. L., Reynolds, S. H., Boone, L. R., Maronpot, R. R., and Anderson, M. W. (1987). Activation of the K-ras protooncogene in lung tumors from rats and mice chronically exposed to tetranitromethane. Cancer Res.47,3212\u20133219."},{"key":"key\n\t\t\t\t20171013192915_BIB183","doi-asserted-by":"crossref","unstructured":"Stowers, S. J., Wiseman, R. W., Ward, J. M., Miller, E. C., Miller, J. A., Anderson, M. W., and Eva, A. (1988). Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: A comparison between B6C3F1 mice and Fischer 344 rats. Carcinogenesis9,271\u2013276.","DOI":"10.1093\/carcin\/9.2.271"},{"key":"key\n\t\t\t\t20171013192915_BIB184","unstructured":"Sugio, K., Fukuyama, Y., Sakada, T., Nishioka, K., Yamazaki, K., Ushijima, C., Tsukamoto, S., Ishida, T., and Sugimachi, K. (1998). Second primary cancers after resection of lung adenocarcinoma with ras gene mutation. Anticancer Res.18,3395\u20133398."},{"key":"key\n\t\t\t\t20171013192915_BIB185","unstructured":"Suzuki, Y., Orita, M., Shiraishi, M., Hayashi, K., and Sekiya, T. (1990). Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene5,1037\u20131043."},{"key":"key\n\t\t\t\t20171013192915_BIB186","unstructured":"Takahashi, T., Takahashi, T., Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y., and Ueda, R. (1991). The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene6,1775\u20131778."},{"key":"key\n\t\t\t\t20171013192915_BIB187","unstructured":"Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R., and Sugimachi, K. (1993). Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res.53,2884\u20132887."},{"key":"key\n\t\t\t\t20171013192915_BIB188","doi-asserted-by":"crossref","unstructured":"Taniguchi, Y., Gemma, A., Takeda, Y., Takenaka, K., Niitani, H., Kudoh, S., and Shimada, T. (1996). Stability of p53 tumor suppressor gene mutations during the process of metastasis and during chemotherapy. Lung Cancer14,219\u2013228.","DOI":"10.1016\/0169-5002(95)00548-X"},{"key":"key\n\t\t\t\t20171013192915_BIB189","doi-asserted-by":"crossref","unstructured":"Tannapfel, A., Busse, C., Weinans, L., Benicke, M., Katalinic, A., Geissler, F., Hauss, J., and Wittekind, C. (2001). INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene20,7104\u20137109.","DOI":"10.1038\/sj.onc.1204902"},{"key":"key\n\t\t\t\t20171013192915_BIB190","doi-asserted-by":"crossref","unstructured":"Tomizawa, Y., Kohno, T., Fujita, T., Kiyama, M., Saito, R., Noguchi, M., Matsuno, Y., Hirohashi, S., Yamaguchi, N., Nakajima, T., et al. (1999). Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma. Oncogene18,1007\u20131014.","DOI":"10.1038\/sj.onc.1202384"},{"key":"key\n\t\t\t\t20171013192915_BIB191","doi-asserted-by":"crossref","unstructured":"Ton, T. V., Hong, H. H., Anna, C. H., Dunnick, J. K., Devereux, T. R., Sills, R. C., and Kim, Y. (2004). Predominant K-ras codon 12 G \u2192 A transition in chemically induced lung neoplasms in B6C3F1 Mice. Toxicol. Pathol.32,16\u201321.","DOI":"10.1080\/01926230490260682"},{"key":"key\n\t\t\t\t20171013192915_BIB192","doi-asserted-by":"crossref","unstructured":"Top, B., Mooi, W. J., Klaver, S. G., Boerrigter, L., Wisman, P., Elbers, H. R., Visser, S., and Rodenhuis, S. (1995). Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer. Int. J. Cancer64,83\u201391.","DOI":"10.1002\/ijc.2910640203"},{"key":"key\n\t\t\t\t20171013192915_BIB193","doi-asserted-by":"crossref","unstructured":"Tseng, R. C., Change, J. W., Hsien, F. J., et al. (2005). Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int. J. Cancer117,241\u2013247.","DOI":"10.1002\/ijc.21178"},{"key":"key\n\t\t\t\t20171013192915_BIB194","doi-asserted-by":"crossref","unstructured":"Unsal, H., Yakicier, C., Marcais, C., Kew, M., Volkmann, M., Zentgraf, H., Isselbacher, K. J., and Ozturk, M. (1994). Genetic heterogeneity of hepatocellular carcinoma. Proc. Natl. Acad. Sci. U.S.A.91,822\u2013826.","DOI":"10.1073\/pnas.91.2.822"},{"key":"key\n\t\t\t\t20171013192915_BIB195","doi-asserted-by":"crossref","unstructured":"Vautier, G., Bomford, A. B., Portmann, B. C., Metivier, E., Williams, R., and Ryder, S. D. (1999). p53 Mutations in British patients with hepatocellular carcinoma: Clustering in genetic hemochromatosis. Gastroenterology117,154\u2013160.","DOI":"10.1016\/S0016-5085(99)70562-7"},{"key":"key\n\t\t\t\t20171013192915_BIB196","unstructured":"Vesey, D. A., Hayward, N. K., and Cooksley, W. G. (1994). p53 gene in hepatocellular carcinomas from Australia. Cancer Detect. Prev.18,123\u2013130."},{"key":"key\n\t\t\t\t20171013192915_BIB197","doi-asserted-by":"crossref","unstructured":"Volkmann, M., Schiff, J. H., Hajjar, Y., Otto, G., Stilgenbauer, F., Fiehn, W., Galle, P. R., and Hofmann, W. J. (2001). Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma. J. Mol. Med.79,594\u2013600.","DOI":"10.1007\/s001090100244"},{"key":"key\n\t\t\t\t20171013192915_BIB198","doi-asserted-by":"crossref","unstructured":"Von Tungeln, L. S., Xia, Q., Bucci, T., Heflich, R. H., and Fu, P. P. (1999). Tumorigenicity and liver tumor ras-protooncogene mutations in CD-1 mice treated neonatally with 1- and 3-nitrobenzo[a]pyrene and their trans-7,8-dihydrodiol and aminobenzo[a]pyrene metabolites. Cancer Lett.137,137\u2013143.","DOI":"10.1016\/S0304-3835(98)00341-3"},{"key":"key\n\t\t\t\t20171013192915_BIB199","doi-asserted-by":"crossref","unstructured":"Wang, X., and Witschi, H. (1995). Mutations of the Ki-ras protooncogene in 3-methylcholanthrene and urethan-induced and butylated hydroxytoluene-promoted lung tumors of strain A\/J and SWR mice. Cancer Lett.91,33\u201339.","DOI":"10.1016\/0304-3835(94)03715-U"},{"key":"key\n\t\t\t\t20171013192915_BIB200","unstructured":"Wang, Y., Wang, Y., Stoner, G., and You, M. (1993). ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H\/HeJ and (C3H x A\/J)F1 mice. Cancer Res.53,1620\u20131624."},{"key":"key\n\t\t\t\t20171013192915_BIB201","doi-asserted-by":"crossref","unstructured":"Warshawsky, D., Talaska, G., Jaeger, M., Collins, T., Galati, A., You, L., and Stoner, G. (1996). Carcinogenicity, DNA adduct formation and K-ras activation by 7H-dibenzo[c,g]carbazole in strain A\/J mouse lung. Carcinogenesis17,865\u2013871.","DOI":"10.1093\/carcin\/17.4.865"},{"key":"key\n\t\t\t\t20171013192915_BIB202","doi-asserted-by":"crossref","unstructured":"Watson, M. A., Devereux, T. R., Malarkey, D. E., Anderson, M. W., and Maronpot, R. R. (1995). H-ras oncogene mutation spectra in B6C3F1 and C57BL\/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells. Carcinogenesis16,1705\u20131710.","DOI":"10.1093\/carcin\/16.8.1705"},{"key":"key\n\t\t\t\t20171013192915_BIB203","doi-asserted-by":"crossref","unstructured":"Weihrauch, M., Lehnert, G., Kockerling, F., Wittekind, C., and Tannapfel, A. (2000). p53 Mutation pattern in hepatocellular carcinoma in workers exposed to vinyl chloride. Cancer88,1030\u20131036.","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1030::AID-CNCR12>3.0.CO;2-4"},{"key":"key\n\t\t\t\t20171013192915_BIB204","doi-asserted-by":"crossref","unstructured":"Weihrauch, M., Markwarth, A., Lehnert, G., Wittekind, C., Wrbitzky, R., and Tannapfel, A. (2002). Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver. Hum. Pathol.33,884\u2013892.","DOI":"10.1053\/hupa.2002.126880"},{"key":"key\n\t\t\t\t20171013192915_BIB205","doi-asserted-by":"crossref","unstructured":"Wiseman, R. W., Stowers, S. J., Miller, E. C., Anderson, M. W., and Miller, J. A. (1986). Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse. Proc. Natl. Acad. Sci. U.S.A.83,5825\u20135829.","DOI":"10.1073\/pnas.83.16.5825"},{"key":"key\n\t\t\t\t20171013192915_BIB206","unstructured":"Wong, N., Lai, P., Pang, E., Fung, L. F., Sheng, Z., Wong, V., Wang, W., Hayashi, Y., Perlman, E., Yuna, S., et al. (2000). Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin. Cancer Res.6,4000\u20134009."},{"key":"key\n\t\t\t\t20171013192915_BIB207","doi-asserted-by":"crossref","unstructured":"Xia, Q., Yi, P., Zhan, D. J., Von Tungeln, L. S., Hart, R. W., Heflich, R. H., and Fu, P. P. (1998). Liver tumors induced in B6C3F1 mice by 7-chlorobenz[a]anthracene and 7-bromobenz[a]anthracene contain K-ras protooncogene mutations. Cancer Lett.123,21\u201325.","DOI":"10.1016\/S0304-3835(97)00366-2"},{"key":"key\n\t\t\t\t20171013192915_BIB208","doi-asserted-by":"crossref","unstructured":"Xue, W., and Warshawsky, D. (2005). Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol. Appl. Pharm.206,73\u201393.","DOI":"10.1016\/j.taap.2004.11.006"},{"key":"key\n\t\t\t\t20171013192915_BIB209","unstructured":"Yanez, L., Groffen, J., and Valenzuela, D. M. (1987). c-K-ras mutations in human carcinomas occur preferentially in codon 12. Oncogene1,315\u2013318."},{"key":"key\n\t\t\t\t20171013192915_BIB210","doi-asserted-by":"crossref","unstructured":"Yang, M., Zhou, H., Kong, R. Y., Fong, W. F., Ren, L. Q., Liao, X. H., Wang, Y., Zhuang, W., and Yang, S. (1997). Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China. Mutat. Res.381,25\u201329.","DOI":"10.1016\/S0027-5107(97)00142-5"},{"key":"key\n\t\t\t\t20171013192915_BIB211","doi-asserted-by":"crossref","unstructured":"You, L., Wang, D., Galati, A. J., Ross, J. A., Mass, M. J., Nelson, G. B., Wilson, K. H., Amin, S., Stoner, J. C., Nesnow, S., et al. (1994). Tumor multiplicity, DNA adducts and K-ras mutation pattern of 5-methylchrysene in strain A\/J mouse lung. Carcinogenesis15,2613\u20132618.","DOI":"10.1093\/carcin\/15.11.2613"},{"key":"key\n\t\t\t\t20171013192915_BIB212","doi-asserted-by":"crossref","unstructured":"You, M., Wang, Y., Lineen, A. M., Gunning, W. T., Stoner, G. D., and Anderson, M. W. (1992b). Mutagenesis of the K-ras protooncogene in mouse lung tumors induced by N-ethyl-N-nitrosourea or N-nitrosodiethylamine. Carcinogenesis13,1583\u20131586.","DOI":"10.1093\/carcin\/13.9.1583"},{"key":"key\n\t\t\t\t20171013192915_BIB213","doi-asserted-by":"crossref","unstructured":"You, M., Wang, Y., Nash, B., and Stoner, G. D. (1993). K-ras mutations in benzotrichloride-induced lung tumors of A\/J mice. Carcinogenesis14,1247\u20131249.","DOI":"10.1093\/carcin\/14.6.1247"},{"key":"key\n\t\t\t\t20171013192915_BIB214","doi-asserted-by":"crossref","unstructured":"You, M., Wang, Y., Stoner, G., You, L., Maronpot, R., Reynolds, S. H., and Anderson, M. (1992a). Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc. Natl. Acad. Sci. U.S.A.89,5804\u20135808.","DOI":"10.1073\/pnas.89.13.5804"},{"key":"key\n\t\t\t\t20171013192915_BIB215","unstructured":"Zhu, M., Guangyu, G., Fangmei, L., Wenliang, W., and Yimin, D. (2002). Interaction of hepatitis B virus with tumor suppressor gene p53: Its significance and biological function. Prog. Nat. Sci.12,24\u201329."}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/90\/2\/400\/17672694\/kfj101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T02:55:25Z","timestamp":1586660125000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/toxsci\/article\/90\/2\/400\/1658557\/Genetic-Alterations-in-Cancer-Knowledge-System"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,12]]},"references-count":214,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,1,12]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfj101","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,4]]},"published":{"date-parts":[[2006,1,12]]}}}